Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report. (December 2016)
- Record Type:
- Journal Article
- Title:
- Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report. (December 2016)
- Main Title:
- Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report
- Authors:
- Kuroda, Takeshi
Takeuchi, Hiroyuki
Nozawa, Yukiko
Sato, Hiroe
Nakatsue, Takeshi
Wada, Yoko
Moriyama, Hiroshi
Nakano, Masaaki
Narita, Ichiei - Abstract:
- Abstract Background Pneumocystis jirovecii pneumonia (PCP) is potentially fatal infectious complication in patients with rheumatoid arthritis (RA) during immunosuppressive therapy. Hospital survival due to human immunodeficiency virus—unrelated PCP reaches to 60 %. The high mortality rate results from difficulties in establishing an early diagnosis, concurrent use of prophylactic drugs, possible bacterial coinfection. We herein report a case of PCP in RA patients who developed the architectural distortions of lung in spite of combined modality therapy. Case presentation A 73-year-old Japanese woman with RA was admitted with shortness of breath. Five weeks previously, she had been started on etanercept in addition to methotrexate (MTX). Chest computed tomography (CT) demonstrated diffuse ground glass opacities distributed throughout the bilateral middle to lower lung fields, and serum β-d -glucan was elevated. Bronchoalveolar lavage fluid revealed noP. jirovecii, but the organism was detected by polymerase chain reaction method. Trimethoprim/sulfamethoxazole was administered with methylprednisolone pulse therapy. However, the follow-up chest X-ray and chest CT demonstrated aggravation of the pneumonia with architectural distortions. Additional direct hemoperfusion with polymyxin B-immobilized fibers and intravenous cyclophosphamide therapy were insufficiently effective, and the patient died on day 25. Conclusion The architectural distortions of lung should be considered as aAbstract Background Pneumocystis jirovecii pneumonia (PCP) is potentially fatal infectious complication in patients with rheumatoid arthritis (RA) during immunosuppressive therapy. Hospital survival due to human immunodeficiency virus—unrelated PCP reaches to 60 %. The high mortality rate results from difficulties in establishing an early diagnosis, concurrent use of prophylactic drugs, possible bacterial coinfection. We herein report a case of PCP in RA patients who developed the architectural distortions of lung in spite of combined modality therapy. Case presentation A 73-year-old Japanese woman with RA was admitted with shortness of breath. Five weeks previously, she had been started on etanercept in addition to methotrexate (MTX). Chest computed tomography (CT) demonstrated diffuse ground glass opacities distributed throughout the bilateral middle to lower lung fields, and serum β-d -glucan was elevated. Bronchoalveolar lavage fluid revealed noP. jirovecii, but the organism was detected by polymerase chain reaction method. Trimethoprim/sulfamethoxazole was administered with methylprednisolone pulse therapy. However, the follow-up chest X-ray and chest CT demonstrated aggravation of the pneumonia with architectural distortions. Additional direct hemoperfusion with polymyxin B-immobilized fibers and intravenous cyclophosphamide therapy were insufficiently effective, and the patient died on day 25. Conclusion The architectural distortions of lung should be considered as a cause of death of PCP. For this reason, a high suspicion of this infectious complication must be kept in mind in order to establish an early diagnosis and treatment in patients with RA managed with MTX and biologics. … (more)
- Is Part Of:
- BMC research notes. Volume 9:Number 1(2016)
- Journal:
- BMC research notes
- Issue:
- Volume 9:Number 1(2016)
- Issue Display:
- Volume 9, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 9
- Issue:
- 1
- Issue Sort Value:
- 2016-0009-0001-0000
- Page Start:
- 1
- Page End:
- 7
- Publication Date:
- 2016-12
- Subjects:
- Rheumatoid arthritis -- Etanercept -- Pneumocystis jirovecii pneumonia -- Architectural distortions -- Case report
Medicine -- Periodicals
Biology -- Periodicals
610.5 - Journal URLs:
- http://www.biomedcentral.com/bmcresnotes ↗
http://www.biomedcentral.com/bmcresnotes/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s13104-016-2052-0 ↗
- Languages:
- English
- ISSNs:
- 1756-0500
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9820.xml